High Failure Rate of Strattice Hernia Mesh Leads to Lawsuits

By Rheingold Giuffra Ruffo & Plotkin LLP

In spite of hundreds of complaints about the Strattice hernia mesh failure and need for revision surgery, the manufacturer took no steps to warn the public or healthcare professionals about the high failure rate and its defects.

Strattice Reconstructive Tissue Matrix is a pig skin mesh product that was introduced in 2008, for use during hernia repair procedures.

The biological mesh is constructed from pig skin, and preserved in a phosphate buffered aqueous solution. It is known as a cross-linked graft device, which is intended to chemically link the proteins in the tissue together. However, cross-linking has been linked to a risk of foreign body response and infections, according to allegations raised in a growing number of lawsuits over infected Strattice mesh now being filed by individuals who received the product.

The Strattice hernia mesh had been recommended for smokers, those who are obese, or recovering from an infection.  However, the high failure rate demonstrates that the mesh’s design isn’t effective and potentially dangerous, causing other medical issues such as the need for revision surgery.

Currently, there are hundreds of lawsuits filed against the manufacturer of the Strattice hernia mesh coordinated in a state court in New Jersey. 

Related Posts